交易 Bristol Myers BMY

出售
 購買

BristolMyers實時圖表

5m 15m 30m 1h 4h 1d 1w

金融工具基礎知識

Weekly Search
Weekly
Daily
日期 關閉 更改 更改(%)： 開倉 高 低

最新新聞

Frances Wang 2025 Apr 22, 16:00

歐洲央行會降息嗎？利率如何影響債券市場？

Frances Wang 2025 Apr 22, 16:00

關稅新聞：亞洲市場上漲，日元因關稅談判下跌

Frances Wang 2025 Apr 22, 16:00

今日AMD股價：影響AMD股價的因素

Frances Wang 2025 Apr 21, 16:00

今日股市：道瓊斯、標普500和納斯達克因特朗普批評聯邦儲備主席鮑威爾而下跌

Frances Wang 2025 Apr 21, 16:00

亞洲股市指數：恆生指數下跌，日經225指數下滑，印度Sensex上漲

Frances Wang 2025 Apr 21, 16:00

今日金價：XAUUSD超過3,400美元，面對關稅不確定性

Frances Wang 2025 Apr 21, 16:00

今日外匯市場：美元跌至三年低點，USD/CHF接近0.8102

Frances Wang 2025 Apr 20, 16:00

現在值得考慮的股票：Nu股票是一個好選擇嗎？

聯絡方式

點差

0.31

點差(%)

0.6404 %

槓桿

1:10

隔夜利息（買入）

-0.0597 %

隔夜利息（賣出）

-0.0292 %

貨幣

USD

交易時間

市場關閉

星期四

13:31 - 19:59

星期一

13:31-19:59

星期二

13:31-19:59

星期三

13:31-19:59

星期五

13:31-19:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

101972574208

流通股份

2034759936

收益日期（下一個）

2001-08-07

現金殖利率 

2025-05-01

除息日

2025-04-04

遠期年股息率

2.48

遠期年現金殖利率

0.0507

每股盈餘

-4.41

了解有關此金融工具的詳細資訊

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

相關工具

資產
出售
購買
更改(%)：

立即交易

立即交易

立即交易

立即交易
查看所有金融工具
Trustpilot